World Health Organization, 2002. Report of the Expert Committee on the Control of Chagas Disease. Geneva: World Health Organization, 115.
Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, Marsh K, Cutts FT, 2007. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 196 :550–557.
Lorca M, Veloso C, Munoz P, Bahamonde MI, Garcia A, 1995. Diagnostic value of detecting specific IgA and IgM with recombinant Trypanosoma cruzi antigens in congenital Chagas’ disease. Am J Trop Med Hyg 52 :512–515.
Truyens C, Hermann E, Alonso-Vega C, Rodriguez P, Vekemans J, Torrico F, Carlier Y, 2005. Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi.Rev Soc Bras Med Trop 38 (Suppl 2):96–100.
Lin S, Sartori MJ, Mezzano L, de Fabro SP, 2005. Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas’ disease. Placenta 26 :789–795.
Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES, 2007. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 14 :1045–1049.
Luquetti AO, Ponce C, Ponce E, Esfandiari J, Schijman A, Revollo S, Anez N, Zingales B, Ramgel-Aldao R, Gonzalez A, Levin MJ, Umezawa ES, Franco da Silveira J, 2003. Chagas’ disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi.Diagn Microbiol Infect Dis 46 :265–271.
Ponce C, Ponce E, Vinelli E, Montoya A, de Aguilar V, Gonzalez A, Zingales B, Rangel-Aldao R, Levin MJ, Esfandiari J, Umezawa ES, Luquetti AO, da Silveira JF, 2005. Validation of a rapid and reliable test for diagnosis of Chagas’ disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J Clin Microbiol 43 :5065–5068.
Cruz-Reyes A, Pickering-Lopez JM, 2006. Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years–a review. Mem Inst Oswaldo Cruz 101 :345–354.
Guzman-Bracho C, 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 17 :372–376.
Lopez-Cardenas J, Gonzalez Bravo FE, Salazar Schettino PM, Gallaga Solorzano JC, Ramirez Barba E, Martinez Mendez J, Sanchez-Cordero V, Peterson AT, Ramsey JM, 2005. Fine-scale predictions of distributions of Chagas disease vectors in the state of Guanajuato, Mexico. J Med Entomol 42 :1068–1081.
Dumonteil E, 1999. Update on Chagas’ disease in Mexico. Salud Publica Mex 41 :322–327.
Cortez MR, Emperaire L, Piccinali RV, Gurtler RE, Torrico F, Jansen AM, Noireau F, 2007. Sylvatic Triatoma infestans (Reduviidae, Triatominae) in the Andean valleys of Bolivia. Acta Trop 102 :47–54.
Pizarro JC, Lucero DE, Stevens L, 2007. PCR reveals significantly higher rates of Trypanosoma cruzi infection than microscopy in the Chagas vector, Triatoma infestans: high rates found in Chuquisaca, Bolivia. BMC Infect Dis 7 :66.
Blanco SB, Segura EL, Cura EN, Chuit R, Tulian L, Flores I, Garbarino G, Villalonga JF, Gurtler RE, 2000. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health 5 :293–301.
Coll-Cardenas R, Espinoza-Gomez F, Maldonado-Rodriguez A, Reyes-Lopez PA, Huerta-Viera M, Rojas-Larios F, 2004. Active transmission of human Chagas disease in Colima Mexico. Mem Inst Oswaldo Cruz 99 :363–368.
Guzman-Bracho C, Lahuerta S, Velasco-Castrejon O, 1998. Chagas disease. First congenital case report. Arch Med Res 29 :195–196.
Sosa-Estani S, 2005. Congenital transmission of Trypanosoma cruzi infection in Argentina. Rev Soc Bras Med Trop 38 (Suppl 2):29–32.
Moncayo A, 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the southern cone countries. Mem Inst Oswaldo Cruz 98 :577–591.
Velasco-Castrejon O, Valdespino JL, Tapia-Conyer R, Salvatierra B, Guzman-Bracho C, Magos C, Llausas A, Gutierrez G, Sepulveda J, 1992. Seroepidemiology of Chagas disease in Mexico. Salud Publica Mex 34 :186–196.
Pan American Health Organization, 2006. Acuerdos y recomendaciones de la IXa reunión anual de la IPCA (Guatemala, 11–13 September 2006), 2007: 5.
Pan American Health Organization, 2004. XIIa reunión de la comisión intergubernamental del cono sur para la eliminación de triatoma infestans y la interrupción de la transmisión transfusional de la tripanosomiasis americana (INCOSUR/Chagas, March 26– 28, 2003), 2007: 24. Available at: http://www.paho.org/Spanish/AD/DPC/CD/dch-XII-INCOSUR-inf-final-arg.pdf. Accessed December 3, 2007.
Zaidemberg M, Spillmann C, Carrizo Páez R, 2004. Control de Chagas en la Argentina. su evolución. Rev Arg de Cardiol 72 :375–380.
Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N, Villa L, Torrico F, Albajar-Vinas P, 2008. Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood. J Clin Microbiol 46 :2022–2027.
Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, Candia N, Calcena MF, Figueredo A, 1998. Treatment of congenital Chagas’ disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59 :487–491.
Garcia A, Bahamonde M, Verdugo S, Correa J, Pastene C, Solari A, Tassara R, Lorca M, 2001. Trypanosoma cruzi transplacental infection: situation in Chile. Rev Med Chil 129 :330–332.
Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico MC, Dramaix M, Truyens C, Carlier Y, 2004. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 70 :201–209.
Brutus L, Schneider D, Postigo J, Delgado W, Mollinedo S, Chippaux JP, 2007. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg 101 :1159–1160.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 494 | 405 | 20 |
Full Text Views | 320 | 10 | 0 |
PDF Downloads | 105 | 9 | 0 |
We conducted a cross-sectional study of Chagas disease in five endemic areas in Argentina, Bolivia, Honduras, and México to estimate the prevalence of Trypanosoma cruzi–specific antibodies in pregnant women, and to assess the use of a rapid test (Chagas Stat-Pak) to screen for T. cruzi infection at the time of delivery. The prevalence of antibodies to T. cruzi measured by enzyme-linked immunosorbent assay (ELISA) in maternal blood was 5.5% (a range of 0.8–28.8% among the countries) in 2,495 women enrolled. Compared with ELISA in maternal blood samples, the Chagas Stat-Pak rapid test sensitivity and specificity in umbilical cord blood were 94.6% and 99.0%, respectively. These results show the ability for a rapid determination of the presence of T. cruzi–specific antibodies in umbilical cord blood as a pragmatic strategy to screen for infection in pregnant women.
World Health Organization, 2002. Report of the Expert Committee on the Control of Chagas Disease. Geneva: World Health Organization, 115.
Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, Marsh K, Cutts FT, 2007. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 196 :550–557.
Lorca M, Veloso C, Munoz P, Bahamonde MI, Garcia A, 1995. Diagnostic value of detecting specific IgA and IgM with recombinant Trypanosoma cruzi antigens in congenital Chagas’ disease. Am J Trop Med Hyg 52 :512–515.
Truyens C, Hermann E, Alonso-Vega C, Rodriguez P, Vekemans J, Torrico F, Carlier Y, 2005. Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi.Rev Soc Bras Med Trop 38 (Suppl 2):96–100.
Lin S, Sartori MJ, Mezzano L, de Fabro SP, 2005. Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas’ disease. Placenta 26 :789–795.
Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES, 2007. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 14 :1045–1049.
Luquetti AO, Ponce C, Ponce E, Esfandiari J, Schijman A, Revollo S, Anez N, Zingales B, Ramgel-Aldao R, Gonzalez A, Levin MJ, Umezawa ES, Franco da Silveira J, 2003. Chagas’ disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi.Diagn Microbiol Infect Dis 46 :265–271.
Ponce C, Ponce E, Vinelli E, Montoya A, de Aguilar V, Gonzalez A, Zingales B, Rangel-Aldao R, Levin MJ, Esfandiari J, Umezawa ES, Luquetti AO, da Silveira JF, 2005. Validation of a rapid and reliable test for diagnosis of Chagas’ disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J Clin Microbiol 43 :5065–5068.
Cruz-Reyes A, Pickering-Lopez JM, 2006. Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years–a review. Mem Inst Oswaldo Cruz 101 :345–354.
Guzman-Bracho C, 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 17 :372–376.
Lopez-Cardenas J, Gonzalez Bravo FE, Salazar Schettino PM, Gallaga Solorzano JC, Ramirez Barba E, Martinez Mendez J, Sanchez-Cordero V, Peterson AT, Ramsey JM, 2005. Fine-scale predictions of distributions of Chagas disease vectors in the state of Guanajuato, Mexico. J Med Entomol 42 :1068–1081.
Dumonteil E, 1999. Update on Chagas’ disease in Mexico. Salud Publica Mex 41 :322–327.
Cortez MR, Emperaire L, Piccinali RV, Gurtler RE, Torrico F, Jansen AM, Noireau F, 2007. Sylvatic Triatoma infestans (Reduviidae, Triatominae) in the Andean valleys of Bolivia. Acta Trop 102 :47–54.
Pizarro JC, Lucero DE, Stevens L, 2007. PCR reveals significantly higher rates of Trypanosoma cruzi infection than microscopy in the Chagas vector, Triatoma infestans: high rates found in Chuquisaca, Bolivia. BMC Infect Dis 7 :66.
Blanco SB, Segura EL, Cura EN, Chuit R, Tulian L, Flores I, Garbarino G, Villalonga JF, Gurtler RE, 2000. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health 5 :293–301.
Coll-Cardenas R, Espinoza-Gomez F, Maldonado-Rodriguez A, Reyes-Lopez PA, Huerta-Viera M, Rojas-Larios F, 2004. Active transmission of human Chagas disease in Colima Mexico. Mem Inst Oswaldo Cruz 99 :363–368.
Guzman-Bracho C, Lahuerta S, Velasco-Castrejon O, 1998. Chagas disease. First congenital case report. Arch Med Res 29 :195–196.
Sosa-Estani S, 2005. Congenital transmission of Trypanosoma cruzi infection in Argentina. Rev Soc Bras Med Trop 38 (Suppl 2):29–32.
Moncayo A, 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the southern cone countries. Mem Inst Oswaldo Cruz 98 :577–591.
Velasco-Castrejon O, Valdespino JL, Tapia-Conyer R, Salvatierra B, Guzman-Bracho C, Magos C, Llausas A, Gutierrez G, Sepulveda J, 1992. Seroepidemiology of Chagas disease in Mexico. Salud Publica Mex 34 :186–196.
Pan American Health Organization, 2006. Acuerdos y recomendaciones de la IXa reunión anual de la IPCA (Guatemala, 11–13 September 2006), 2007: 5.
Pan American Health Organization, 2004. XIIa reunión de la comisión intergubernamental del cono sur para la eliminación de triatoma infestans y la interrupción de la transmisión transfusional de la tripanosomiasis americana (INCOSUR/Chagas, March 26– 28, 2003), 2007: 24. Available at: http://www.paho.org/Spanish/AD/DPC/CD/dch-XII-INCOSUR-inf-final-arg.pdf. Accessed December 3, 2007.
Zaidemberg M, Spillmann C, Carrizo Páez R, 2004. Control de Chagas en la Argentina. su evolución. Rev Arg de Cardiol 72 :375–380.
Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N, Villa L, Torrico F, Albajar-Vinas P, 2008. Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood. J Clin Microbiol 46 :2022–2027.
Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, Candia N, Calcena MF, Figueredo A, 1998. Treatment of congenital Chagas’ disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59 :487–491.
Garcia A, Bahamonde M, Verdugo S, Correa J, Pastene C, Solari A, Tassara R, Lorca M, 2001. Trypanosoma cruzi transplacental infection: situation in Chile. Rev Med Chil 129 :330–332.
Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico MC, Dramaix M, Truyens C, Carlier Y, 2004. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 70 :201–209.
Brutus L, Schneider D, Postigo J, Delgado W, Mollinedo S, Chippaux JP, 2007. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg 101 :1159–1160.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 494 | 405 | 20 |
Full Text Views | 320 | 10 | 0 |
PDF Downloads | 105 | 9 | 0 |